drugset / Trial / NCT03545347

Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.

NCT03545347

Phase 2 Completed 29 enrolled Morten Tange Kristensen PT, PhD
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This pilot trial investigates the preliminary effect and safety of a 12 week multi-modal intervention initiated during admission in the acute ward after hip fracture surgery. The intervention under investigation is a combination therapy consisting of physiotherapy, protein-rich nutritional supplement and nandrolone decanoate (Deca-Durabolin) supplement. The investigators expect the combination therapy to be a preliminary effective and safe treatment in elderly patients with hip fracture and that this combination therapy intervention program is more efficacious in improving muscle strength, and physical function 14 weeks after hip fracture surgery, compared to physiotherapy, protein-rich nutritional supplement plus placebo.

Timeline

Start
2018-09-03
Primary completion
2020-05-20
Completion
2020-06-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nandrolone Decanoate Small molecule 50 mg Other
Subject Nandrolone Decanoate Small molecule 100 mg Other
Subject Nandrolone Decanoate Small molecule 200 mg Other

Indications